WASHINGTON, DC -- (MARKET WIRE) -- 06/11/2006 -- The American Diabetes Association (ADA) and Entelos, Inc. (LSE: ENTL) announced today during a press briefing at the ADA's 66th Scientific Sessions their plans to establish an in silico (computer simulation) research facility to support basic research in type 1 diabetes. This facility, which will initially be located at Entelos' Foster City, CA headquarters, will provide researchers with an unparalleled ability to investigate the onset, progression, and treatment of diabetes.
